Maxnerva Technology Services Limited filed its Monthly Return (Form FF301) to the Hong Kong Stock Exchange for the period ended 30 April 2026. The report confirms that the company’s share structure remained unchanged during the month.

Authorised and Issued Share Capital • Authorised share capital stayed at 1.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 100.00 million. • Issued shares were steady at 706.17 million, with no treasury shares held or cancelled.

Public Float The company affirmed compliance with Main Board Rule 13.32B, maintaining at least the 25% public float threshold as of 30 April 2026.

Share Option Position Maxnerva Technology reported 6.92 million share options outstanding across three grants: 1) 31 Aug 2017 grant – 1.35 million options 2) 12 Nov 2018 grant – 2.82 million options 3) 9 Apr 2022 grant – 2.75 million options No options were exercised, cancelled, or lapsed in April, and no funds were raised through option exercises.

Other Equity Instruments The company confirmed that it had no outstanding warrants, convertibles, or other share-issuance agreements during the month.

Overall, the April filing indicates a stable capital base with no share movements and full public float compliance, while 6.92 million options remain a potential source of future dilution.